| European Case Law Identifier: | ECLI:EP:BA:2015:T094313.20150625 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 25 June 2015 | ||||||||
| Case number: | T 0943/13 | ||||||||
| Application number: | 06824315.3 | ||||||||
| IPC class: | A23L 1/308 A23L 1/29 A61P 21/00 A61K 31/702 A61K 31/715 A61K 31/733 A23L 1/30 A61K 35/20 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | COMPOSITION COMPRISING OLIGOSACCHARIDES AS SOLUBLE DIETARY FIBRES FOR USE AGAINST MUSCLE WASTING | ||||||||
| Applicant name: | N.V. Nutricia | ||||||||
| Opponent name: | Fresenius Kabi Deutschland GmbH | ||||||||
| Board: | 3.3.09 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Grounds for opposition - added subject-matter (no) Grounds for opposition - insufficiency of disclosure (no) Novelty - (yes) Inventive step - non-obvious alternative |
||||||||
| Catchwords: |
The causal relationship between the substance or composition on the one hand and the therapeutic effect achieved on the other hand is decisive for the assessment of inventive step of further-medical-use claims (see point 4.1.5). |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t130943eu1.html
Date retrieved: 17 May 2021